Advaxis, Inc. announced Al Blunt, M.D., has joined the company as Vice President of Medical. Dr. Blunt joins Advaxis from Covance, where he was Executive Medical Director for Oncology. Dr. Blunt joined Covance in 1998, holding several positions increasing in responsibility over nearly 20 years. As Vice President of Medical for Advaxis, Dr. Blunt is responsible for leading the company’s clinical development strategy and activities from pre-clinical to commercial phase trials, including development of trial protocols to preparing regulatory filings, and participating in interactions with regulatory authorities relating to clinical matters. Dr. Blunt’s appointment was effective March 7, 2017.